In this paper, a deterministic co-infection model incorporating protection from infection for both pneumonia infection and HIV/AIDS is considered. The model is shown to be positively invariant as well as bounded. Specifically we consider the case of maximum protection against pneumonia and the case of maximum protection against HIV/AIDS. In both cases, the endemic states are shown to exist provided the reproduction number for each case is greater than unity. Furthermore, by use of a suitable Lyapunov function, the endemic states have been shown to be globally asymptotically stable. Numerical sim- 
Introduction
HIV/AIDS continues to be a major global public health issue, having claimed more than 39 million lives so far. Sub-saharan Africa accounts for almost 70% of the global new HIV infections,with 24.7 million people living with HIV by 2013 [16] . As a result of the high HIV prevalence, opportunistic infections(OIs), such as pneumonia which are rare in people with healthy immune systems, are also in high prevalence giving rise to co-infections. A co-infection is the simultaneous infection of the same host with two or more different pathogens or different strains of the same pathogens, leading to coexistence of strains (pathogens) at population level. There are cases where a host who is HIV positive, is infected with pneumonia [8] .
Pneumonia is a lung infection involving the lung alveoli (air sacs), caused by microbes, including bacteria, viruses, or fungi. The viruses which cause pneumonia include influenza A and B viruses; respiratory syncytial virus (RSV); and haemophilus parainfluenzae types 1, 2 and 3. Streptococcus pneumoniae is the most common cause of bacterial pneumonia. Haemophilus influenzae type b, group A streptococcus, and Mycobacterium tuberculosis (TB) are bacteria that also cause pneumonia. Pneumonia can be transmitted when airborne microbes from an infected individual are inhaled by an individual. Generally, the symptoms of pneumonia include: cough, difficult breathing, fever, muscle aches, loss of appetite and lethargy [6] . Pneumonia mortality in children is very high especially in the developing world, with an estimate of 5,500 deaths per day [15] . The challenge of scarce resources for treatment of pneumonia necessitates the implementation of programs aimed at preventing the infection. Protective measures against pneumonia may include but not limited to; vaccination, practising good hygiene, avoiding close contacts with sick people and limiting exposure to cigarette smoke [17] .
Upon getting infected with HIV virus, the body's immune system becomes weak and with time, infected individuals progresses to the AIDS stage. Early treatment of HIV-positive people with antiretroviral drugs can lower the viral load set point while prolonging the life of the infected person [5] . Although therapeutic treatment strategies appear promising for retarding the progression of HIV related diseases, prevention remains the most effective strategy against the HIV/AIDS epidemic [1] . Use of condoms has been studied numerously [7, 18] . Lately, public health campaigns against many infections are focusing on protection measures. HIV/AIDS protection may involve abstinence, being faithful, use of condoms, male circumcision among others. Co -infection mathematical models of HIV/AIDS and pneumonia are rare in literature yet the synergy between the two infections exist [8] .
Model Formulation
We formulate a model in which the total human population at any time t denoted by N , is subdivide into subclasses, S(t) the class of individuals susceptible to both pneumonia and HIV/AIDS infection, P P , individuals who are protected against pneumonia. The protection is lost at the rate α 1 . The class I P consists of individuals who are infected with pneumonia at a rate λ P . Treatment for pneumonia is assumed to be successful and is done at the rate ε. The class T P consists of individuals who have recovered from pneumonia infection. Mortality occurs among pneumonia patients at the rate δ P , while natural death is assumed to occur in all classes at the rate µ.
The class P H consist of individuals who are protected against HIV/AIDS infection. For various forms of protection against HIV/AIDS, see for instance [18, 14] . This protection may be lost due to risky behaviour at the rate α 2 . Since the modes of transmission for the two diseases are different and also for purposes of simplicity we do not assume dual protection for pneumonia and HIV/AIDS. The class I H is made up of individuals who are asymptomatically infected with HIV/AIDS. This infection occurs at the rate λ H . In the absence of intervention (therapy), individuals develop symptoms of HIV/AIDS and progress from the class I H to the class I A at the rate τ . Mortality occurs among HIV/AIDS patients at the rate δ A . Individuals in the class I H can acquire pneumonia at the rate ϕ 1 λ P and progress to the class I HP , where ϕ 1 is a modification parameter accounting for the fact that individuals who have HIV virus are more susceptible to pneumonia infection than HIV negative individuals due to immunosuppression. Individuals in the class I A can also acquire pneumonia at the rate ϕ 2 λ P , where ϕ 2 > ϕ 1 and progress to the class I AP . In the absence of intervention (therapy), individuals in the class I HP develop symptoms of HIV/AIDS and progress to the class I AP at the rate τ , where is a modification parameter. Upon effective pneumonia treatment, individuals in the class I HP and I AP move to the classes I H and I A respectively. Mortality occurs due to the dual infection of HIV/AIDS and pneumonia at a rate δ AP . Individuals in the class I P can acquire HIV/AIDS at a rate κλ H and progress to the class I HP where 0 < κ < 1 is a modification parameter accounting for the fact that individuals infected with pneumonia, due to morbidity have reduced activity and are less susceptible.
The total population
We define the rate at which individuals acquire pneumonia as
where π is the probability that one will acquire pneumonia upon contact with pneumonia infected individuals and θ is the contact rate with pneumonia infected individuals while φ 2 > φ 1 are modification parameters accounting for the assumed increased infectivity due to dual infection.
The rate at which individual acquire HIV/AIDS is defined as
where β is the probability that susceptible individuals acquire HIV upon contact with an HIV infected individual and C is the effective contact rate with HIV/AIDS infected individuals. ω 3 > ω 2 > ω 1 , are modification parameters showing the infectious rate per class.with the assumption that an individual who is asymptomatic with HIV/AIDS and has pneumonia is more infectious of HIV/AIDS than one asymptomatically infected with HIV/AIDS. Similarly AIDS individuals are more infectious than individuals asymptomatic with HIV/AIDS due to high viral load [9] .
HIV/AIDS prevalence denoted by Φ will be
This study seeks to investigate the effect of protection for HIV/AIDS and pneumonia in the co-infection model. Let χ P and χ H denote the probability of success of protection against pneumonia and HIV/AIDS respectively. The modified forces of infection λ p P and λ p H become
and
From the above definitions, the resulting flow diagram for the co-infection is given below.
Figure 1:The flow diagram for the pneumonia and HIV/AIDS co-infection
The mathematical model defined by a system of differential equations based on the above flow diagramme is given by dS dt
where νΛ is the constant recruitment rate into the class of individuals protected against pneumonia, γΛ is the constant recruitment rate into the class of individuals protected against HIV and (1 − ν − γ)Λ is the constant recruitment rate into the class of susceptible individuals to both pneumonia and HIV virus.
Model Analysis
Based on the fact that the model deals with human population, all the state variables and parameters are assumed to be non-negative ∀t ≥ 0. This model is studied in the feasible region Ω, where
To show that our solutions are bounded in the set Ω, we take the time derivative of N from Equation (7), thus we have
which upon integration yields
where N (0) is the initial total population. Clearly as t → ∞ we have
which shows that the set of solutions is bounded. With the assumption of positivity of solutions and having established that the same are bounded, the model Equation (7) is epidemiologically well posed in the region Ω
The case of maximum protection against pneumonia
In this case the probability of the success of protection is unity, That is χ P = 1. Assuming that there are no new pneumonia infections in the population, then λ P = I P = 0. Therefore Equation (7) becomes
The force of infectionλ
h H Equation (6) is now defined as as
The basic reproduction numberR H , computed using the next generation matrix method approach [13] for Equation (12) is given by
The endemic state is defined as
For an infection to be endemic in a population, I * H > 0. This inequality holds provided that R H > 1 with ( 
Local stability of the endemic equilibrium
The long term behaviour of Equation (12) can be deduced from its stability analysis. From Equation (12) N = S + P P + P H + I H + I A . We can study the first four equations of Equation (12) since I A = N − (S + P P + P H + I H ). Thus
The Jacobian of Equation (16) at the endemic state E * 1 (S * , P * P , P * H , I * H ) is given by
Clearly −(α 2 + µ) is an eigenvalue of Equation (17) . The other eigenvalues can be obtained from the reduced matrix defined by
The trace of Equation (18) is negative and its determinant is given by
detJ(E * 12 ) > 0 provided that
Since the trace is negative and the determinant is positive provided that inequality (20) and inequality (21) hold, the eigenvalues of Equation (18) will have negative real parts. Therefore the endemic equilibrium E * 1 (S * , P * P , P * H , I * H ) is locally asymptotically stable.
Global stability of the endemic equilibrium
The global stability of the equilibria are obtained by means of Lyapunov's direct method and LaSalle's invariance principle [4] . Consider the non-linear Lyapunov function V e : (S, P P , P H , I H , I A ) ∈ Ω ⊂ R 5 + : S, P P , P H , I H , I A > 0
defined as
where V e is C 1 in the interior of the region Ω. E * 1 is the global minimum of V e on Ω and V e : (S, P P , P H , I H , I A ) = 0. The time derivative of Equation (23) is given by
HenceV e < 0. We see thatV e = 0 iff S = S * , P H = P * H , P P = P * P , I H = I * H and I A = I * A . Thus the largest compact invariant set in {S, P H , P P , I H , I A } ∈ Ω : V e = 0 is the Singleton E * 1 , where E * 1 is the endemic equilibrium. Thus E * 1 is globally asymptotically stable in the interior of the region Ω.
Case of maximum protection against HIV/AIDS
In this case the probability of the success of protection is unity, i.e χ H = 1. Assuming that there are no new HIV/AIDS infections in the population, then λ H = I H = I A = 0. Therefore Equation (7) becomes
The force of infection Equation (5) is now defined as
while the basic reproduction number is given by
For the infection to be endemic in a population I * P > 0. From Equation (25)
provided R P > 1 with δ P < πθ(1 − χ P ).
Local stability of the endemic equilibrium
The total population N from Equation (25) is N = S + P P + P H + I P + T P for which T P = N − S + P P + P H + I P . Thus we study the first four equations of Equation (25) at the endemic state E * 2 (S * , P * H , P * P I * P ).
The Jacobian of Equation (29) is given by
Clearly −(µ + α 1 ) is an eigenvalue of Equation (30). To obtain the other eigenvalues, we analyze the system
trJ(E * 21 ) < 0 and
detJ(E * 21 ) is positive since (1 − χ P ) > 0. Therefore the endemic equilibrium E * 2 (S * , P * H , P * P I * P ) is locally asymptotically
Global stability of the endemic equilibrium
Consider the non-linear Lyapunov function
where V is C 1 in the interior of the region Ω. E * 2 is the global minimum of V on Ω and V : (S, P P , P H , I P , T P ) = 0. The time derivative of Equation (34) is given by
With the derivatives of S, P P , P H , I P , T P defined in Equation (25) and by using (1−ν−γ)Λ = −α 1 P * P +(µ+λ p P )S * , νΛ−(µ+α 1 )P * P , γΛ−(µ+λ p P )P * H , λ p P (P H + S) = (µ + ε + δ P )I * P , and εT P = µT P into Equation (35) we obtaiṅ
henceV < 0. Thus E * 2 is globally asymptotically stable in the interior of the region Ω.
NUMERICAL SIMULATIONS
To graphically illustrate the effect of protection on the dynamics of infection, numerical simulations are carried out. The graph I P against P P
Discussion
From Figure 1(a) , we observe that, with a low protection rate the probability of infection is high and therefore the number of infectives I H rises sharply in a short span before drastically dropping. This sharp drop may be attributed to the depletion of susceptibles or the susceptibles embracing protective measures. From the same figure a very high protection rate with a low probability of transmission results in reduced disease prevalence. From Figure 1(b) , a low protection rate results in increased I A cases. This is because it has been medically proven that increased viral load for HIV persons leads to a faster rate of progression to the symptomatic stage. On the contrary, when the protection rate is high then I A cases are low. From Figure 2 , we observe that the number of I H infections reduces with increased protection.
From Figure 3 , a high rate of protection against pneumonia leads to a low probability of disease transmission and a low protection rate leads to a high disease prevalence. Figure 4 shows that the number of I P infectives reduces with increased protection.
In order to reduce the number of new HIV/AIDS and pneumonia infections, and reduce their impact on individual, families and communities, there is need to employ strategies such as increasing the public awareness drive to behaviour change and encourage openness, increasing access to voluntary HIV testing and counselling, promoting increased condom use to reduce the spread of HIV infection, improving access to antiretroviral drugs (ARV's) for people living with AIDS, practising proper hygiene, eating a balanced diet and vaccination in the case of pneumonia. These strategies will help in reducing the economic burden that are borne by a country in giving care and treating the infected individuals. As evidenced from these results, it is indeed true that prevention is better than cure. These results are consistent with results such as by [1] .
Conclusion
In this work, we formulated a model for the co-infection of HIV/AIDS with pneumonia incorporating protection. To investigate the effect of protection, two cases were considered, namely the case of maximum protection against HIV/AIDS and the case of maximum protection against pneumonia. The existence of the endemic equilibrium for the two cases was established and the stability of the same was analysed. In both cases the endemic equilibrium is found to be globally asymptotically stable. This implies that at peak times of the reoccurrence of the diseases, the levels of infections are manageable with minimal interventions. From the numerical simulations, we observe that protection against a disease has the effect of reducing the disease prevalence.
Protection from HIV/AIDS infection may include measures such as use of condoms, male circumcision among others, while protection from pneumonia infection may involve vaccination, adequate nutrition, good hygiene and addressing environmental factors such as air pollution. The model developed and analyzed in this research does dot take into account the specific contributions of individual protective measures. Instead, protection had been used in a general sense. Models which incorporates specific protective measures may be considered for further research. This will guide policy makers on which particular protective measures to implement and emphasize as a means of reducing disease prevalence rates.
